JPMorgan Chase & Co. Grows Stock Position in SIGA Technologies, Inc. (NASDAQ:SIGA)

JPMorgan Chase & Co. increased its position in shares of SIGA Technologies, Inc. (NASDAQ:SIGA) by 154.4% in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 70,299 shares of the company’s stock after purchasing an additional 42,669 shares during the period. JPMorgan Chase & Co. owned approximately 0.10% of SIGA Technologies worth $475,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Larson Financial Group LLC acquired a new stake in shares of SIGA Technologies in the third quarter valued at about $30,000. EP Wealth Advisors LLC acquired a new stake in shares of SIGA Technologies during the 3rd quarter valued at approximately $82,000. XTX Topco Ltd acquired a new stake in shares of SIGA Technologies in the 3rd quarter worth approximately $85,000. China Universal Asset Management Co. Ltd. increased its stake in SIGA Technologies by 64.3% in the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 13,727 shares of the company’s stock valued at $93,000 after purchasing an additional 5,372 shares in the last quarter. Finally, AQR Capital Management LLC acquired a new position in SIGA Technologies during the second quarter worth $99,000. Institutional investors and hedge funds own 55.40% of the company’s stock.

SIGA Technologies Stock Performance

SIGA Technologies stock opened at $6.20 on Wednesday. SIGA Technologies, Inc. has a fifty-two week low of $4.26 and a fifty-two week high of $12.83. The firm has a market capitalization of $442.68 million, a price-to-earnings ratio of 5.17 and a beta of 0.94. The stock’s fifty day moving average is $6.38 and its two-hundred day moving average is $7.48.

SIGA Technologies (NASDAQ:SIGA) last issued its quarterly earnings data on Thursday, November 7th. The company reported $0.02 earnings per share (EPS) for the quarter. The business had revenue of $10.01 million for the quarter. SIGA Technologies had a return on equity of 49.06% and a net margin of 49.33%. As a group, sell-side analysts forecast that SIGA Technologies, Inc. will post 1.04 EPS for the current fiscal year.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.